RiverPark Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-215,109
Closed -$15M 143
2022
Q1
$15M Sell
215,109
-41,331
-16% -$3.02M 2.75% 8
2021
Q4
$20M Buy
256,440
+76,634
+43% +$6.76M 2.4% 10
2021
Q3
$17.2M Buy
179,806
+73,651
+69% +$7.78M 2.1% 14
2021
Q2
$13.2M Hold
106,155
1.68% 24
2021
Q1
$14M Sell
106,155
-3,356
-3% -$459K 2.31% 17
2020
Q4
$14.5M Sell
109,511
-43,980
-29% -$5.32M 2.55% 14
2020
Q3
$15.6M Buy
153,491
+40,090
+35% +$3.46M 3.52% 7
2020
Q2
$9.86M Buy
113,401
+25,773
+29% +$2.06M 3.07% 8
2020
Q1
$5.08M Buy
87,628
+43,594
+99% +$3.54M 2.91% 9
2019
Q4
$4.07M Buy
44,034
+17,979
+69% +$1.58M 1.71% 24
2019
Q3
$2.35M Hold
26,055
1.07% 40
2019
Q2
$3.08M Hold
26,055
1.32% 32
2019
Q1
$2.26M Sell
26,055
-12,957
-33% -$1.1M 0.98% 41
2018
Q4
$2.46M Sell
39,012
-17,186
-31% -$1.18M 1.08% 34
2018
Q3
$4.43M Buy
56,198
+29,841
+113% +$1.95M 1.06% 31
2018
Q2
$1.58M Buy
+26,357
New +$1.42M 0.32% 48

Other funds holding EXAS

RiverPark Advisors's EXAS Position: Q2 2022 in Review

RiverPark Advisors sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 215,109 shares — an estimated $15M sold.

RiverPark Advisors first reported a position in EXAS in Q2 2018 and held it in 16 quarters. The position peaked at $20M in Q4 2021. 500 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

  • RiverPark Advisors reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
  • RiverPark Advisors sold 215,109 Exact Sciences shares in Q2 2022, an estimated $15M.
  • RiverPark Advisors first reported a position in Exact Sciences in Q2 2018 and held it in 16 quarters.
  • RiverPark Advisors's Exact Sciences position peaked at $20M in Q4 2021.
  • 500 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on RiverPark Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.